Technical Leadership for Complex Pharmaceutical Challenges
Helping pharmaceutical organizations restore compliance, reduce risk, and return confidently to production.
Executive direction and hands-on implementation across pharmaceutical quality, microbiology, and regulatory work, from the strategy that leadership signs off on to the change carried out on the floor.
Where engagements usually begin
Four situations account for most of the work. Each one is a technical problem before it is a compliance problem.
An FDA observation or an FDA Form 483
A response that has to be credible and executed, not written and filed.
Contamination and monitoring trends
Excursions and adverse trends that need scientific investigation, not a document exercise.
A facility that has to start up
Commissioning and qualification where microbiology and quality systems must be right before manufacturing begins.
Growth, commercialization, or IPO readiness
Capability and organizational readiness built before demand and diligence arrive.
Scientific Investigation Resulting in Manufacturer Process Improvement
- Challenge
- During qualification activities supporting the startup of a GMP biotechnology manufacturing facility, air visualization studies identified an unexpected anomaly within a newly installed Biological Safety Cabinet (BSC).
- Response
- Working collaboratively with the equipment manufacturer, independent technical specialists, and executive leadership, the investigation ultimately identified a previously unrecognized manufacturing issue at the vendor level.
- Impact
- The findings resulted in improvements to the manufacturer's production process while reinforcing the importance of objective scientific investigation and evidence-based decision making.
Further selected engagements
All engagementsThe RIBS Method™
Recover, Improve, Build, Scale. The strongest engagement solves today's challenge while building the knowledge, systems, documentation, and people needed for long-term success.
Stabilize the risk and establish what actually happened
Contain the problem, separate fact from assumption, and reach a position that can be defended. Investigation before conclusions.
Correct the system, not only the record
Change the method, practice, or facility behavior that produced the problem, then show that the change holds in normal operation.
Put capability, documentation, and people in place
Laboratories, microbiology and environmental monitoring programs, quality systems, and trained analysts, so the answer does not leave with the engagement.
Make it hold as volume and scrutiny increase
Extend proven capability across commercialization, technology transfer, and organizational growth, and prepare for the examination that follows.
Bring the situation, and the first conversation will be technical.
A review covers what has happened, where the regulatory exposure sits, and what would have to be true to return confidently to production.